Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction： a Muti-center, Open-label, Randomized Controlled Trial

NCT05292404 is registered in ClinicalTrials.gov with Shanghai Tong Ren Hospital as lead sponsor.

NCT NCT05292404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction： a Muti-center, Open-label, Randomized Controlled Trial
Lead sponsor
Shanghai Tong Ren Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2022
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction